Carboxymethylierte Galactomannanprodukte als galenische Hilfsstoffe = Galactomannanes carboxyméthylés comme excipients 2nd Commun: examination microscopique et sorption d'eau = Carboxy methylated galactomannanes for use as excipients 2nd Commun: microscopic examination and sorption of waterNÜRNBERG, E; PRÜTTING, D.Acta pharmaceutica technologica. 1984, Vol 30, Num 1, pp 50-55, issn 0340-3157Article

The bioterrorism Act: Its effect on the import and registration of pharmaceutical excipientsFALK, Arthur J.Pharmaceutical technology (2003). 2004, Vol 28, Num 1, pp 78-84, issn 1543-2521, 4 p.Article

Excipient functionalityMORETON, R. Christian.Pharmaceutical technology (2003). 2004, Vol 28, Num 5, pp 98-99, issn 1543-2521, 2 p., 119 [3 p.]Article

Synthetic excipients challenge all-natural organics: Offer advantages/challenges to developers and formulatorsRUSSELL, Ronnelle.Pharmaceutical technology (2003). 2004, Vol 28, Num 4, pp 38-50, issn 1543-2521, 7 p.Article

Drug excipientsKALASZ, Huba; ANTAL, Istvan.Current medicinal chemistry. 2006, Vol 13, Num 21, pp 2535-2563, issn 0929-8673, 29 p.Article

Xylan: a possible filler and disintegrant for tabletsJUSLIN, M; PARONEN, P.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 4, pp 256-257, issn 0022-3573Article

Compression characteristics of basic tricalcium phosphate (Ca₃(PO₄)₂, Ca(OH)₂)XIN PU HOU; CARSTENSEN, J. T.International journal of pharmaceutics. 1985, Vol 25, Num 2, pp 207-215, issn 0378-5173Article

Papers presented at the polymers as drug release agents symposium, 23 March 1983 at the Society of Chemical Industry, LondonBritish polymer journal. 1983, Vol 15, Num 4, issn 0007-1641, 86 p.Conference Proceedings

Les édulcorants = SweetenersHERAUD, G.Gazette médicale de France (1969). 1984, Vol 91, Num 11, pp 95-100, issn 0016-5557, 4 p.Article

Carboxymethylierte Galaktomannan-Produkte als Galenische Hifsstoffe. III: Carboxymethyl-Galaktomannane als Matrixbildner für Retard-Zubereitungen = Les galactomannanes carboxyméthyles comme adjuvant galénique III: Les galactomannanes comme matrice pour les formulations de formes retard = Carboxymethylated galactomannan products as galenic inactive ingredientsNÜRNBERG, E; PRÜTTING, D.Pharmazeutische Industrie. 1984, Vol 46, Num 2, pp 184-186, issn 0031-711XArticle

Evaluation of cyclodextrin polymer as an additive for furosemide tabletFENYVESI, E; TAKAYAMA, K; SZEJTLI, J et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 670-677, issn 0009-2363Article

Crystallization of excipients in tabletsANDO, H; WATANABE, S; OHWAKI, T et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 2, pp 128-131, issn 0022-3549Article

Indentation Test for Free-Flowable Powder ExcipientsZATLOUKAL, Zdenek; SKLUBALOVA, Zdenka.Pharmaceutical development and technology. 2008, Vol 13, Num 1, pp 85-92, issn 1083-7450, 8 p.Article

INAKTIVE BESTANDTEILE PHARMAZEUTISCHER PRAEPARATE = ADJUVANT INACTIF DANS LES FORMES PHARMACEUTIQUESCOOPER J.1979; PHARM. INDUSTR.; DEU; DA. 1979; VOL. 41; NO 1; PP. 70-80; ABS. ENG; BIBL. 22 REF.Article

LES PROPRIETES HOMOLYTIQUES DES MEDICAMENTS ET LA STABILITE DES FORMES MEDICAMENTEUSES. I. L'INTERACTION DES PRODUITS MEDICAMENTEUX AVEC LES HYDROPEROXYDES ET LA STABILITE DES FORMES MEDICAMENTEUSES AVEC DES EXCIPIENTS LIPIDIQUESTENTSOVA AI; GOL'DENBERG VI; PIL'KO EK et al.1978; KHIMIKO-FARM. ZH.; S.S.S.R.; DA. 1978; VOL. 12; NO 1; PP. 128-132; BIBL. 5 REF.Article

Examination of natural gums as matrices for sustained release of theophyllineNAKANO, M; OGATA, A.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 782-785, issn 0009-2363Article

The effect of film-inducing substances on the characteristics of binary powder mixturesSAMAHA, M. W; EL GINDY, N. A.International journal of pharmaceutics. 1984, Vol 19, Num 1, pp 63-74, issn 0378-5173Article

Anthralin stability in various vehiclesGREEN, P. G; KENNEDY, C. T. C; FORBES, D. R et al.Journal of the American Academy of Dermatology. 1987, Vol 16, Num 5, pp 984-988, issn 0190-9622, 1Article

Bestimmung der Helikalität gelöster Gelatine = Détermination de l'hélicité de la gélatine dissoute = Determination of the helicality of dissolved gelatineHÜTTENRAUCH, R; FRICKE, S; ZIELKE, P et al.Pharmazie. 1984, Vol 39, Num 5, issn 0031-7144, 350Article

Bestimmung des Ölverhaltens von weissem Vselin DAB 8 = Absorption d'huile par les vaselines blanches DAB8 = Oil absorption of white petrolatum DAB8SCHMIEDEL, R.Acta pharmaceutica technologica. 1984, Vol 30, Num 1, pp 78-84, issn 0340-3157Article

Properties of cyclodextrin polymer as a tabletting aidFENYVESI, E; SHIRAKURA, O; SZEJTLI, J et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 665-669, issn 0009-2363Article

Solubility of acetazolamide and chlorthalidone in mixed aqueous solvent systemIBRAHIM, S. A; SHAWKY, S.Pharmazeutische Industrie. 1984, Vol 46, Num 4, pp 412-416, issn 0031-711XArticle

Comparative evaluation of maltose as excipient for direct compressionMICHOEL, A; ROMBAUT, P; KINGET, R et al.Pharmazeutische Industrie. 1983, Vol 45, Num 9, pp 892-896, issn 0031-711XArticle

Polymer effects on ocular bioavailability: the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbitsSAETTONE, M. F; GIANNACCINI, B; RAVECCA, S et al.International journal of pharmaceutics. 1984, Vol 20, Num 1-2, pp 187-202, issn 0378-5173Article

Sorption und oxidative Veränderungen von 3-Butylhydroxyanisol (3-BHA) in SiO₂-Dispersionen. I: Sorptionsverhalten von 3-BHA = Adsorption et altération oxydatives de l'anisol (butylhydroxy-3) dans des dispersions de silice = Adsorption and oxidative alterations of 3-butylhydroxyanisole (3-BHA) in silica dispersionsTISCHINGER-WAGNER, H; RUPPRECHT, H.Pharmazeutische Industrie. 1984, Vol 46, Num 3, pp 275-278, issn 0031-711XArticle